Form 8-K - Current report:
SEC Accession No. 0000950170-25-028369
Filing Date
2025-02-27
Accepted
2025-02-27 07:35:09
Documents
13
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20250227.htm   iXBRL 8-K 55720
2 EX-99.1 dyn-ex99_1.htm EX-99.1 131702
3 GRAPHIC img259164492_0.jpg GRAPHIC 103686
  Complete submission text file 0000950170-25-028369.txt   459565

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dyn-20250227.xsd EX-101.SCH 30688
15 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20250227_htm.xml XML 4519
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 25673049
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)